pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·58m ago·1 min read
save

Trump administration proposes new Medicare Advantage audit rule aiming to curb fraud and save $90 billion

Nov 16, 2026·read at STAT ↗RegulatoryNeutral

The Trump administration on Monday proposed new regulations that would reissue Biden-era rules and focus on more aggressive audits of Medicare Advantage plans to combat fraud.

Officials say the rule will prevent fraud, remove bad actors, and protect beneficiaries of Medicare, Medicaid and ACA marketplaces, promising $90 billion in taxpayer savings over the next decade.

The projected savings are expected to come not from stopping fraudulent hospice or wheelchair claims, but from tighter audits of Medicare Advantage plans, a policy long discussed by regulators.

The change could affect health insurers and pharmaceutical companies that depend on Medicare Advantage reimbursements, as stricter audits may influence payment flows and pricing strategies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: New Trump regulation promises to crush ‘fraudsters.’ All the savings come from Medicare Advantage”

read at STAT ↗
497 words · retrieved 13m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

no entities indexed yet

related stories

  • 3h agoSTAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for RocheSTAT
  • 4h agoSTAT+: Federal judge issues final ruling blocking U.S. plan to limit visa length for grad students, postdocsSTAT
  • 5h agoSTAT+: In a win for MAHA, FDA creates new regulatory category for the supplement NACSTAT
  • 6h agoSTAT+: Expert warns of battleground over global access to newer GLP-1 drugs for obesitySTAT
  • 6h agoSTAT+: NIAID acting head John Powers III appointed as the permanent directorSTAT